FB-704A

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameFB-704A
Drug Alias NameFB-704FB-704A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-6 inhibitors
TargetsInterleukin-6
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFountain Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesOneness Biotech Co Ltd
Inactive CompaniesFountain Biopharma Inc
Active IndicationsAsthma
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A